Gossamer Bio, Inc. (GOSS) Financials

$1.93

$0.2 (11.24%)
Last update: 04:00 PM EST
Day's range
$1.75
Day's range
$1.95
$200M$200M$100M$100M$0$0-$100M-$100M-$200M-$200M-$300M-$300MEarning20182018201920192020202020212021202220222023202320242024-48%-48%-48.5%-48.5%-49%-49%-49.5%-49.5%-50%-50%-50.5%-50.5%Profit Margin
Profit Margin
Revenue
Earnings

GOSS Income statement / Annual

Last year (2024), Gossamer Bio, Inc.'s total revenue was $114.70 M, and the percentage change from the previous year is not available. In 2024, Gossamer Bio, Inc.'s net income was -$56.53 M. See Gossamer Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $114.70 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $4.39 M $4.43 M $5.17 M $4.27 M $3.09 M $297.00 K $0.00 $0.00
Gross Profit $114.70 M -$4.39 M -$4.43 M -$5.17 M -$4.27 M -$3.09 M -$297.00 K $0.00 $0.00
Gross Profit Ratio 1 0 0 0 0 0 0 0 0
Research and Development Expenses $138.49 M $145.30 M $170.92 M $170.27 M $160.85 M $143.40 M $55.28 M $891.00 K $0.00
General & Administrative Expenses $36.13 M $38.46 M $47.61 M $45.78 M $49.73 M $39.14 M $44.05 M $262.00 K $83.00 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $36.13 M $38.46 M $47.61 M $45.78 M $49.73 M $39.14 M $44.05 M $262.00 K $83.00 K
Other Expenses $0.00 $0.00 $1.51 M $799.00 K -$174.00 K $5.83 M $316.00 K $0.00 $0.00
Operating Expenses $174.62 M $183.76 M $218.53 M $216.05 M $210.58 M $182.54 M $99.33 M $1.15 M $83.00 K
Cost And Expenses $174.62 M $183.76 M $218.53 M $216.05 M $210.58 M $182.54 M $99.33 M $1.15 M $83.00 K
Interest Income $1.78 M $2.00 M $1.58 M $761.00 K $3.44 M $3.63 K $1.72 M $0.00 $0.00
Interest Expense $11.52 M $13.51 M $13.88 M $19.44 M $12.67 M $0.00 $12.00 K $118.00 K $0.00
Depreciation & Amortization $4.15 M $1.61 M $4.43 M $5.17 M $4.27 M $3.09 M $297.00 K $1.15 M $83.00 K
EBITDA -$39.97 M -$172.15 M -$211.07 M -$209.32 M -$233.96 M -$186.14 M -$148.99 M -$6.65 M -$83.00 K
EBITDA Ratio -0.35 0 0 0 0 0 0 0 0
Operating Income Ratio -0.52 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $4.28 M $3.94 M -$10.79 M -$17.88 M -$9.40 M $5.83 M $2.02 M -$118.00 K $0.00
Income Before Tax -$55.64 M -$179.82 M -$229.38 M -$234.00 M -$243.36 M -$180.31 M -$146.97 M -$6.77 M -$83.00 K
Income Before Tax Ratio -0.49 0 0 0 0 0 0 0 0
Income Tax Expense $893.00 K $0.00 $10.85 M $15.07 M $8.22 M $511.00 K $0.00 $0.00 $0.00
Net Income -$56.53 M -$179.82 M -$240.23 M -$249.08 M -$251.58 M -$180.82 M -$146.97 M -$6.77 M -$83.00 K
Net Income Ratio -0.49 0 0 0 0 0 0 0 0
EPS -0.25 -0.8 -2.84 -3.33 -3.67 -3.3 -2.43 -0.27 -0.0091
EPS Diluted -0.25 -1.18 -2.84 -3.33 -3.67 -3.3 -2.43 -0.27 -0.0091
Weighted Average Shares Out $226.23 M $225.57 M $84.57 M $74.84 M $68.51 M $54.74 M $60.40 M $24.83 M $9.16 M
Weighted Average Shares Out Diluted $226.23 M $225.57 M $84.57 M $74.84 M $68.51 M $54.74 M $60.40 M $24.83 M $9.16 M
Link